期刊文献+

降糖速度对2型糖尿病合并冠心病患者肌酸激酶同工酶和肌红蛋白的影响 被引量:4

The influence of glucose-lowering rate on CKMB and muscle hemoglobin in type 2 diabetes mellitus with coronary heart disease
原文传递
导出
摘要 通过对151例2型糖尿病合并冠心病(T2DMC)患者和142例2型糖尿病患者在降糖过程中肌酸激酶同工酶(CKMB)和肌红蛋白水平变化的研究,寻找2型糖尿病患者合理的降糖速度。2型糖尿病组CKMB水平在随访时较降糖前后均下降(P〈0.05),当空腹或餐后2h降糖速度≤6mmol·L^-1·d^-1时,CKMB与肌红蛋白水平随访时较降糖前均有显著下降(P〈0.05),当空腹降糖速度〉6mmol·L^-1·d^-1时,CKMB水平降糖后较降糖前显著升高(P〈0.05);T2DMC组空腹或餐后2h降糖速度≤4mmol·L^-1·d^-1时,CKMB与肌红蛋白水平随访时较降糖前显著下降(P〈0.05或P〈O.01),当空腹降糖速度〉4mmol·L^-1·d^-1时,CKMB与肌红蛋白水平随访时较降糖前显著升高(P〈0.05)。 One hundred and fifty-one type 2 diabetic patients with coronary heart disease ( T2 DMC ) and 142 cases of type 2 diabetes mellitus were included for analyzing the influence of different glucose-lowering rates on MB isoenzyme of creatine kinase ( CKMB ) and muscle hemoglobin level changes to search for the rational glucose-lowering rate. The level of CKMB in type 2 diabetes mellitus group was significantly lower( P〈O. 05 ) at follow-up than thatbefore and after intensive therapy. In type 2 diabetes mellitus group, when the fasting or postprandial glucose-lowering rate was not greater than 6 mmol·L^-1·d^-1, the level of CKMB and muscle hemoglobin were significantly lower at follow-up than that before intensive therapy ( P 〈 0.05 ). When the fasting glucose-lowering rate is greater than 6 mmol·L^-1·d^-1, the level of CKMB is significantly higher after intensive therapy than that before glucose-lowering (P〈0.05). In T2DMC group, when the fasting or postprandial glucose-lowering rate was not greater than 4 mmol·L^-1·d^-1, the level of CKMB and muscle hemoglobin was significantly lower at follow-up than that before intensive therapy( P〈0.05 or P〈O. 01 ), but higher at follow-up when the fasting glucose-lowering rate was greater than 4 mmol·L^-1·d^-1(P〈O. 05 ).
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第5期407-411,共5页 Chinese Journal of Endocrinology and Metabolism
基金 黑龙江省教育厅基金(11541133)
关键词 糖尿病 2型 冠心病 降糖速度 肌酸激酶同工酶 肌红蛋白 Diabetes mellitus, type 2 Coronary heart disease Glucose-lowering rate MB isoenzyme ofcreatine kinase Muscle hemoglobin
  • 相关文献

参考文献11

  • 1Hu DY, Pan CY, Yu JM, et al. The relationship between coronary artery disease and abnomal glucose regulation in China : the China Heart Survey. Eur Heart J, 2006,27:2573-2579.
  • 2The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008.358:2545-2559.
  • 3The ADVANCE collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med, 2008,358:2560-2572.
  • 4Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 2009, 360 : 129-139.
  • 5Park L, Wexler D. Update in diabetes and cardiovascular disease: synthesizing the evidence from recent trials of glycemic control to prevent cardiovascular disease. Curr Opin Lipidol, 2010,21:8-14.
  • 6Brown A, Reynolds LR, Bruemmer D. Intensive glycemic control and cardiovasculardisease: an update. Nat Rev Cardiol, 2010, 7:369- 375.
  • 7孙振杰,吴伟华,王明丽,邓巍,杨磊,孙丽芳,苗佳晶,郑召辉,薛瑞凤,黄金玮.降糖速率对2型糖尿病合并冠心病患者左心功能影响[J].中华内分泌代谢杂志,2010,26(12):1050-1053. 被引量:4
  • 8Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med, 2004,141:421-431.
  • 9Abdel-Maksoud M, Sazonov V, Gutkin SW, et al. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. J Cardiovasc Pharmacol, 2008,51:331-351.
  • 10Kajikawa Y, Ikeda M, Takemoto S, et al. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J, 2011,52 : 17-22.

二级参考文献9

  • 1陈新军,苏伟,郑若龙,李伟章,高春恒,孙有刚.左心房容积指数在评价急性心肌梗死病例预后中的价值[J].中国心血管杂志,2007,12(1):27-29. 被引量:3
  • 2Hafiner SM.Cardiovascular risk factors and the prediabetic syndrome.Ann Med,1996,28:363-370.
  • 3The Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of intensive glucose lowering in type 2 diabetes.N Engl J Med,2008,358:2545-2559.
  • 4The ADVANCE collaborative group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N Engl J Med,2008,358:2560-2572.
  • 5Duckworth W,Abraira C,Moritz T,et al.Glucose control and vascular complications in veterans with type 2 diabetes.N Engl J Med,2009,360:129-139.
  • 6Gaede P,Lund-Andersen H,Parving HH,et al.Effect of a multffactorial intervention on mortality in type 2 diabetes.N Engl J Med,2008,358:580-591.
  • 7Dart AM,Otterstad JE,Kirwan BA,et al.Predictive value of local and core laboratory echocardiographic assessment of cardiac function in patients with chronic stable angina:The ACTION study.Eur J Echocardiogr,2007,8:275-283.
  • 8Ammar KA,Redfield MM,Mahoney DW,et al.Central obesity:association with left ventricular dysfunction and mortality in the community.Am Heart J,2008,156:975-981.
  • 9Jackson S,Smith V,Gottdiener J,et al.The impact of cardiovascular risk factors on the age-related excess risk of coronary heart disease.Int J Epidemiol,2006,31:547-552.

共引文献3

同被引文献40

  • 1Fukuhara A. Matsuda M. Nishizawa M. et a1. Visfatin: a pro?tein secreted by visceral fat that mimics the effects of insulin[J]. Science. 2005.307 (5708): 426-430.
  • 2LuoJ. RossouwJ. Margolis KL. Smoking cessation. weight change. and coronary heart disease among postmenopausal women with and without diabetes[J].JAMA. 2013. 310 (1): 94-96.
  • 3Hage FG. Lusa L. Dondi M. et a1. Exercise stress tests for de?tecting myocardial ischemia in asymptomatic patients with diabe?tes mellitus[J]. AmJ Cardiol , 2013. ll2 (1): l4-20.
  • 4Kato M. Matsumoto N. Nakano Y. et al. Combined assessment of myocardial perfusion and function by ECG- gated myocardial perfusion single- photon emission computed tomography for the prediction of future cardiac events in patients with type 2 diabetes mellitus[J]. CircJ. zon , 75 (2): 376- 382.
  • 5Battes L. Barendse R. Steyerberg EW. et a1. Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease[J]' AmJ Cardiol , 2013. ll2 (1): 27-33.
  • 6Tamis-HollandJE. LuJ. Korytkowski M. et a1. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization , a report from the BAR I 2D Trial (Bypass Angioplasty Revascularization Inves?tigation 2 Diabetes)[J].J Am Coll Cardiol , 2013. 61 (17): 1767-1776.
  • 7Daniels LB. Grady D. Mosca L. et al. Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial[J]. Circ Cardiovasc Qual Outcomes. 2013. 6 (2): 164-170.
  • 8Dagenais GR. LuJ. Faxon DP. et al. Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary ar- tery disease: results from the BARI 2D (Bypass Angioplasty Re?vascularization Investigation 2 Diabetes) trial[J].J Am Coll Cardiol , 2013. 61 (7): 702-71l.
  • 9Sanchez-Aguilar M. Tapis-PerezJH. Sanchez-RodriguezJ J. et al. Effect of rosuvastatin on cytokines after traumatic head injury[J].J Neurosurg , 2013. 118 (3): 669-675.
  • 10张春玉,吕申,王波,苏本利.糖尿病大鼠骨代谢变化与立普妥、胰岛素的干预效应[J].中国组织工程研究与临床康复,2007,11(45):9026-9030. 被引量:4

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部